Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.76 USD | +2.31% | -2.70% | -36.84% |
Mar. 20 | Cytek Biosciences Insider Sold Shares Worth $269,600, According to a Recent SEC Filing | MT |
Mar. 19 | Cytek Biosciences Appoints William McCombe as CFO, Reaffirms 2024 Guidance | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Neutral | Neutral |
Resistance | 6.290 | 9.510 | 9.510 |
Spread/Res. | -8.43% | -39.43% | -39.43% |
Spread/Supp. | +2.31% | +40.49% | +33.03% |
Support | 5.630 | 4.100 | 4.330 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- CTKB Stock
- Charts Cytek Biosciences, Inc.